Market Overview

Cyberonics Announces Results from E-36 Study Of AspireSR Generator at AES

Share:

Cyberonics (NASDAQ: CYBX) announced today that results from the E-36 clinical study of the AspireSR generator were presented at the annual  AES Meeting, taking place December 6-10 at the Walter E. Washington Convention Center in Washington, D.C.  

The study met its primary endpoint in that the AspireSR generator, with IntelliSense cardiac-based seizure detection, detected more than

See full press release

Posted-In: News Guidance Management Global

 

Related Articles (CYBX)

View Comments and Join the Discussion!
Need corporate guidance data?
Click here to see licensing options.
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Benzinga's Weekend M&A Chatter

Disney's 'Frozen' Grosses $31.6M this Weekend; Lionsgate's 'The Hunger Games: Catching Fire' Global Total Now $673.4M